UNICREDIT BANK/CALL/BIOGEN IDEC/350/0.1/18.06.25 Stock

Warrant

DE000HC7N1H6

Market Closed - BOERSE MUENCHEN 15:40:28 2024-05-17 EDT
0.89 EUR -2.20% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/350/0.1/18.06.25
Current month+58.93%
1 month+134.21%
Date Price Change
24-05-17 0.89 -2.20%
24-05-16 0.91 -9.90%
24-05-15 1.01 +26.25%
24-05-14 0.8 +2.56%
24-05-13 0.78 +14.71%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 03:40 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC7N1H
ISINDE000HC7N1H6
Date issued 2023-06-23
Strike 350 $
Maturity 2025-06-18 (397 Days)
Parity 10 : 1
Emission price 4.76
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.39
Lowest since issue 0.33
Delta0.23x
Omega 5.324
Premium56.09x
Gearing23.31x
Moneyness 0.6588
Difference Strike 119.4 $
Difference Strike %+34.12%
Spread 0.02
Spread %2.17%
Theoretical value 0.9100
Implied Volatility 37.03 %
Total Loss Probability 87.08 %
Intrinsic value 0.000000
Present value 0.9100
Break even 359.89 €
Theta-0.03x
Vega0.07x
Rho0.04x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6 USD
Average target price
285.9 USD
Spread / Average Target
+24.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW